Molecular Epidemiology of Biliary Tree Cancers
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorM.D. Anderson Cancer Center
About this trial
This study is to learn if certain risk factors (environmental, viral, behavioral, medical, and dietary), tumor markers, and genetic changes can predict the development and outcome of biliary tree cancers. Establishing biomarkers models from patients may help doctors to further understand how biliary tree cancer is affected by different treatments, and why some people's cancer responds differently than others.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Pathologically or radiologically confirmed diagnosis of CGC or GBC
With or without prior radiation or chemotherapy
All United States of America (USA) and non USA residents
No age, gender, or racial restriction
Disqualifiers
None
Trial population
Patients with biliary tree cancer and healthy participants
Trial design
Design model
Case-control
Time perspective
Prospective
Treatments tested in this trial
Biospecimen Collection
Procedure/SurgeryUndergo collection of tissue, and blood
Questionnaire Administration
Other interventionComplete questionnaire
Treatment groups
1,500 Participants
are divided into 1 treatment groupGroup A: Observational (biospecimen collection, questionnaire)2 interventions
Trial outcomes
Primary outcomes
1
Significant factors that may contribute to the etiology of biliary tree cancer
Time frame
through study completion, an average of 1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov